Myron Kaplan - 14 Jan 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Director
Signature: /s/ Myron Kaplan
Issuer symbol: CRMD
Transactions as of: 14 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 18 Jan 2023, 18:00:50 UTC
Previous filing: 18 May 2022
Next filing: 19 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CRMD	Common Stock						160,034	14 Jan 2023	Direct
holding	CRMD	Common Stock						20,000	14 Jan 2023	Spouse	F1
holding	CRMD	Common Stock						10,000	14 Jan 2023	Spouse as Guardian for Grandchildren	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRMD	Stock Option (Right to Buy Common Stock)	Award	$0	+20,000		$0.000000	20,000	14 Jan 2023	Common Stock	20,000	$4.43	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F2	These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.